Literature DB >> 371476

Laetrile: end play around the FDA. A review of legal developments.

G M Rosen, R I Shorr.   

Abstract

We consider here some of the legal and political background behind today's laetrile controversy. First, we provide a brief historical review of our present food and drug legislation and discuss details of these laws with respect to attempts by laetrile's backers to use the courts in the legalization of this compound. We analyze one case, Rutherford v. United States, that was won in the lower courts by the advocates of laetrile and conclude that the courts may have allowed emotionalism to interfere with the process of rational decision-making. On a larger scale, this emotionalism manifests itself as political pressure that may bring about changes in our food and drug legislation. These changes could loosen restrictions on the effectiveness requirement and result in the sacrifice of consumer protection in favor of making available more drugs, some of them ineffective, from which the patient may choose for treatment.

Entities:  

Keywords:  Rutherford v. United States

Mesh:

Substances:

Year:  1979        PMID: 371476     DOI: 10.7326/0003-4819-90-3-418

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

1.  Looking Back, Looking Forward: The Ethical Framing of Complementary and Alternative Medicine in Oncology Over the Last 20 Years.

Authors:  Brittany C Kimball; Gail Geller; Rahma Warsame; Ashok Kumbamu; Aminah Jatoi; Barbara Koenig; Jon C Tilburt
Journal:  Oncologist       Date:  2018-03-09

Review 2.  Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds.

Authors:  Ewa Jaszczak-Wilke; Żaneta Polkowska; Marek Koprowski; Krzysztof Owsianik; Alyson E Mitchell; Piotr Bałczewski
Journal:  Molecules       Date:  2021-04-13       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.